218 related articles for article (PubMed ID: 33944777)
1. Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate.
Li WH; Huang K; Cai Y; Wang QW; Zhu WJ; Hou YN; Wang S; Cao S; Zhao ZY; Xie XJ; Du Y; Lee CS; Lee HC; Zhang H; Zhao YJ
Elife; 2021 May; 10():. PubMed ID: 33944777
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.
Sasaki Y; Zhu J; Shi Y; Gu W; Kobe B; Ve T; DiAntonio A; Milbrandt J
Exp Neurol; 2021 Nov; 345():113842. PubMed ID: 34403688
[TBL] [Abstract][Full Text] [Related]
3. Multiple domain interfaces mediate SARM1 autoinhibition.
Shen C; Vohra M; Zhang P; Mao X; Figley MD; Zhu J; Sasaki Y; Wu H; DiAntonio A; Milbrandt J
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468661
[TBL] [Abstract][Full Text] [Related]
4. The NAD
Jiang Y; Liu T; Lee CH; Chang Q; Yang J; Zhang Z
Nature; 2020 Dec; 588(7839):658-663. PubMed ID: 33053563
[TBL] [Abstract][Full Text] [Related]
5. SARM1 is a metabolic sensor activated by an increased NMN/NAD
Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
[TBL] [Abstract][Full Text] [Related]
6. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
[TBL] [Abstract][Full Text] [Related]
7. Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1.
Bratkowski M; Xie T; Thayer DA; Lad S; Mathur P; Yang YS; Danko G; Burdett TC; Danao J; Cantor A; Kozak JA; Brown SP; Bai X; Sambashivan S
Cell Rep; 2020 Aug; 32(5):107999. PubMed ID: 32755591
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain.
Feldman HC; Merlini E; Guijas C; DeMeester KE; Njomen E; Kozina EM; Yokoyama M; Vinogradova E; Reardon HT; Melillo B; Schreiber SL; Loreto A; Blankman JL; Cravatt BF
Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2208457119. PubMed ID: 35994671
[TBL] [Abstract][Full Text] [Related]
9. The chemical biology of NAD
Icso JD; Thompson PR
Curr Opin Chem Biol; 2022 Aug; 69():102176. PubMed ID: 35780654
[TBL] [Abstract][Full Text] [Related]
10. Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss.
Wu T; Zhu J; Strickland A; Ko KW; Sasaki Y; Dingwall CB; Yamada Y; Figley MD; Mao X; Neiner A; Bloom AJ; DiAntonio A; Milbrandt J
Cell Rep; 2021 Oct; 37(3):109872. PubMed ID: 34686345
[TBL] [Abstract][Full Text] [Related]
11. Acidic pH irreversibly activates the signaling enzyme SARM1.
Zhao YJ; He WM; Zhao ZY; Li WH; Wang QW; Hou YN; Tan Y; Zhang D
FEBS J; 2021 Dec; 288(23):6783-6794. PubMed ID: 34213829
[TBL] [Abstract][Full Text] [Related]
12. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for SARM1 inhibition and activation under energetic stress.
Sporny M; Guez-Haddad J; Khazma T; Yaron A; Dessau M; Shkolnisky Y; Mim C; Isupov MN; Zalk R; Hons M; Opatowsky Y
Elife; 2020 Nov; 9():. PubMed ID: 33185189
[TBL] [Abstract][Full Text] [Related]
14. SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation.
Summers DW; Gibson DA; DiAntonio A; Milbrandt J
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6271-E6280. PubMed ID: 27671644
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
Bosanac T; Hughes RO; Engber T; Devraj R; Brearley A; Danker K; Young K; Kopatz J; Hermann M; Berthemy A; Boyce S; Bentley J; Krauss R
Brain; 2021 Nov; 144(10):3226-3238. PubMed ID: 33964142
[TBL] [Abstract][Full Text] [Related]
16. The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD
Essuman K; Summers DW; Sasaki Y; Mao X; DiAntonio A; Milbrandt J
Neuron; 2017 Mar; 93(6):1334-1343.e5. PubMed ID: 28334607
[TBL] [Abstract][Full Text] [Related]
17. Emergence of SARM1 as a Potential Therapeutic Target for Wallerian-type Diseases.
Loring HS; Thompson PR
Cell Chem Biol; 2020 Jan; 27(1):1-13. PubMed ID: 31761689
[TBL] [Abstract][Full Text] [Related]
18. A phase transition reduces the threshold for nicotinamide mononucleotide-based activation of SARM1, an NAD(P) hydrolase, to physiologically relevant levels.
Icso JD; Thompson PR
J Biol Chem; 2023 Nov; 299(11):105284. PubMed ID: 37742918
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules.
Shi Y; Kerry PS; Nanson JD; Bosanac T; Sasaki Y; Krauss R; Saikot FK; Adams SE; Mosaiab T; Masic V; Mao X; Rose F; Vasquez E; Furrer M; Cunnea K; Brearley A; Gu W; Luo Z; Brillault L; Landsberg MJ; DiAntonio A; Kobe B; Milbrandt J; Hughes RO; Ve T
Mol Cell; 2022 May; 82(9):1643-1659.e10. PubMed ID: 35334231
[TBL] [Abstract][Full Text] [Related]
20. A Cell-Permeant Mimetic of NMN Activates SARM1 to Produce Cyclic ADP-Ribose and Induce Non-apoptotic Cell Death.
Zhao ZY; Xie XJ; Li WH; Liu J; Chen Z; Zhang B; Li T; Li SL; Lu JG; Zhang L; Zhang LH; Xu Z; Lee HC; Zhao YJ
iScience; 2019 May; 15():452-466. PubMed ID: 31128467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
